Effects of Aerobic Versus Resistance Training on Bone Metabolism in Stage 3-4 Chronic Kidney Disease

NCT ID: NCT07133256

Last Updated: 2025-08-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-01-01

Study Completion Date

2025-07-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This randomized controlled trial investigates the comparative effects of aerobic versus resistance training on bone mineral density (BMD) and bone metabolism markers in patients with stage 3 or 4 chronic kidney disease (CKD). The primary aim is to evaluate the impact of two distinct exercise modalities on serum osteoprotegerin (OPG), receptor activator of nuclear factor kappa-B ligand (RANKL), and the OPG/RANKL ratio, as well as densitometric changes at key skeletal sites.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Chronic kidney disease-mineral and bone disorder (CKD-MBD) is a common complication in non-dialysis CKD patients, driven by disrupted calcium-phosphate metabolism, secondary hyperparathyroidism, and altered bone remodeling pathways, such as the OPG-RANKL axis. Exercise is an emerging non-pharmacological strategy to mitigate skeletal deterioration in CKD, yet the differential effects of aerobic and resistance training on bone health remain poorly understood in this population.

This study recruited 60 CKD patients (stage 3-4, aged 30-50 years) and randomly allocated them into two groups (n=30 each): a resistance training group and an aerobic exercise group. Both groups underwent supervised exercise 3 times per week for six months. Bone mineral density was assessed using dual-energy X-ray absorptiometry (DEXA) at the lumbar spine (L2-L4), femoral neck, and distal radius. Serum concentrations of OPG and RANKL were measured via ELISA at baseline and post-intervention.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Osteopenia Bone Metabolism Disorders Chronic Kidney Disease (Stage 3-4) Mineral and Bone Disorder (CKD-MBD)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Interventional (Clinical Trial)
Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors
None (Open Label)

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Resistance Exercise Group (Group A)

Participants in this arm engaged in supervised resistance training three times per week for six months. Each session included:

5-minute warm-up with dynamic stretching and range-of-motion exercises

30-minute resistance training using weight machines targeting major muscle groups (upper limbs, lower limbs, and trunk)

Intensity: 60% to 80% of one-repetition maximum (1-RM), adjusted progressively

10-minute cool-down with static stretching Sessions were monitored by trained physiotherapists.

Group Type EXPERIMENTAL

Resistance Exercise

Intervention Type BEHAVIORAL

Structured machine-based resistance exercise protocol performed under supervision, targeting osteogenic loading to improve bone mineral density and alter bone metabolism markers in CKD stage 3-4 patients.

Aerobic Exercise Group (Group B)

Participants in this arm performed supervised aerobic exercise (treadmill walking) three times per week for six months. Each session included:

5-minute warm-up

30-minute treadmill walking at 60%-80% of age-predicted maximum heart rate (HRmax = 220 - age)

10-minute cool-down Exercise sessions were supervised by trained exercise professionals and tailored to maintain target heart rate zones.

Group Type ACTIVE_COMPARATOR

Aerobic Training

Intervention Type BEHAVIORAL

Participants in this arm performed supervised aerobic exercise (treadmill walking) three times per week for six months. Each session included:

5-minute warm-up

30-minute treadmill walking at 60%-80% of age-predicted maximum heart rate (HRmax = 220 - age)

10-minute cool-down Exercise sessions were supervised by trained exercise professionals and tailored to maintain target heart rate zones.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Resistance Exercise

Structured machine-based resistance exercise protocol performed under supervision, targeting osteogenic loading to improve bone mineral density and alter bone metabolism markers in CKD stage 3-4 patients.

Intervention Type BEHAVIORAL

Aerobic Training

Participants in this arm performed supervised aerobic exercise (treadmill walking) three times per week for six months. Each session included:

5-minute warm-up

30-minute treadmill walking at 60%-80% of age-predicted maximum heart rate (HRmax = 220 - age)

10-minute cool-down Exercise sessions were supervised by trained exercise professionals and tailored to maintain target heart rate zones.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adults aged 30 to 50 years
* Diagnosed with stage 3 or 4 chronic kidney disease (non-dialysis dependent)
* BMI between 20 and 24 kg/m²
* Not currently taking medications that affect bone density (e.g., corticosteroids, bisphosphonates)
* Non-smokers and abstinent from alcohol
* Not receiving hormone replacement therapy
* Willing and able to participate in supervised exercise sessions for 6 months

Exclusion Criteria

* Diagnosis of type 1 diabetes mellitus
* Uncontrolled hypertension
* History of cardiovascular, musculoskeletal, endocrine, or metabolic bone disease
* Pregnant or planning pregnancy during the study period
* Participation in a structured exercise program within the last 3 months
* Contraindications to exercise as determined by medical evaluation
* Use of investigational drugs or enrollment in another clinical trial during the study period
Minimum Eligible Age

30 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sinai University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Amany Gomaa Atiaa

lecturer

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Dr. Shehab Abd E-Kader, Professor

Role: PRINCIPAL_INVESTIGATOR

1Department of Physical Therapy, Faculty of Medical Rehabilitation Sciences, King Abdulaziz University, Jeddah, Saudi Arabia.

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Manshyet El-Bakry Hospital

Cairo, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SU.REC.2025(45H)

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Osteosarcopenia and Exercise
NCT04526327 COMPLETED NA
Bone Estrogen Strength Training
NCT00000399 COMPLETED PHASE2
Effect of Electromyostimulation on Bone
NCT01296776 COMPLETED PHASE3